|
ESYT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.37667655053519E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.05440047990658E-10 |
| Normal-vs-Stage2 |
2.427200E-04 |
| Normal-vs-Stage3 |
2.14179999999953E-05 |
| Normal-vs-Stage4 |
1.094050E-01 |
| Stage1-vs-Stage2 |
7.560200E-01 |
| Stage1-vs-Stage3 |
7.085900E-02 |
| Stage1-vs-Stage4 |
8.578400E-01 |
| Stage2-vs-Stage3 |
2.767200E-01 |
| Stage2-vs-Stage4 |
7.079800E-01 |
| Stage3-vs-Stage4 |
2.795600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.41997524849558E-12 |
| Normal-vs-AfricanAmerican |
6.04210000032523E-07 |
| Normal-vs-Asian |
1.129380E-01 |
| Caucasian-vs-AfricanAmerican |
3.018200E-01 |
| Caucasian-vs-Asian |
8.042800E-01 |
| AfricanAmerican-vs-Asian |
8.739000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.2255974013442E-11 |
| Normal-vs-Female |
7.89940335366168E-11 |
| Male-vs-Female |
5.077600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.226900E-04 |
| Normal-vs-Extreme_Weight |
1.73069999997999E-06 |
| Normal-vs-Obese |
5.64360003174613E-09 |
| Normal-vs-Extreme_Obese |
6.998100E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.870300E-02 |
| Normal_Weight-vs-Obese |
9.645800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.993600E-02 |
| Extreme_Weight-vs-Obese |
9.618500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
6.643600E-01 |
| Obese-vs-Extreme_Obese |
1.246410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.416300E-04 |
| Normal-vs-Age(41-60Yrs) |
1.42920120183021E-11 |
| Normal-vs-Age(61-80Yrs) |
9.54080037196547E-10 |
| Normal-vs-Age(81-100Yrs) |
1.780090E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.638300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.184390E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.197800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.937940E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.136600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.201000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.04569686243394E-11 |
| Normal-VS-Type2 PRCC |
1.74279999998195E-06 |
| Normal-VS-KIRP CIMP |
2.840900E-03 |
| Normal-VS-Unclassified PRCC |
2.71849999955442E-07 |
| Type1 PRCC-VS-Type2 PRCC |
2.594200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.462400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.302330E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.852030E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.381000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.792000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.67579999999746E-05 |
| Normal-vs-N1 |
2.784100E-04 |
| Normal-vs-N2 |
4.257700E-02 |
| N0-vs-N1 |
7.912200E-01 |
| N0-vs-N2 |
2.783800E-01 |
| N1-vs-N2 |
2.365200E-01 |
|
|
